Skip to main content
Study IDs insulin therapy response predictors in teens with diabetes

Researchers examined 253 adolescents with obesity and type 2 diabetes ages 10 to 17 who underwent insulin therapy and found that elevated insulin sensitivity during randomization and therapy initiation, as well as higher adinopectin at randomization, but not beta-cell function indices, were linked to consistent improvements in A1C levels. The findings in Pediatric Diabetes "support the need for more aggressive therapy in youth with type 2 diabetes," researchers wrote.

Full Story: